Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FOLR1 Recombinant Protein | Login | FOLR1 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| TIGIT Recombinant Protein | Login | TIGIT Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| CRTAM Recombinant Protein | Login | CRTAM Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Glypican 3 Recombinant Protein | Login | Glypican 3 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Glypican 3 Recombinant Protein | Login | Glypican 3 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| M-CSF R Recombinant Protein | Login | M-CSF R Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| M-CSF R Recombinant Protein | Login | M-CSF R Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| TIM-3 Recombinant Protein | Login | TIM-3 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| AIMP1 Recombinant Protein | Login | AIMP1 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Angiopoietin-2 Recombinant Protein | Login | Angiopoietin-2 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| B7-H3 Recombinant Protein | Login | B7-H3 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| B7-H3 Recombinant Protein | Login | B7-H3 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| B7-H5 Recombinant Protein | Login | B7-H5 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| B7-H5 Recombinant Protein | Login | B7-H5 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Betacellulin Recombinant Protein | Login | Betacellulin Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| BTLA Recombinant Protein | Login | BTLA Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| BTN1A1 Recombinant Protein | Login | BTN1A1 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| BTN1A1 Recombinant Protein | Login | BTN1A1 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Carbonic Anhydrase IX Recombinant Protein | Login | Carbonic Anhydrase IX Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| CD117 Recombinant Protein | Login | CD117 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| CD47 Recombinant Protein | Login | CD47 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| CD99 Recombinant Protein | Login | CD99 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| CTLA-4 Recombinant Protein | Login | CTLA-4 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| CX3CL1 Recombinant Protein | Login | CX3CL1 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Dkk-1 Recombinant Protein | Login | Dkk-1 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||


